Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial Results on August 7

Core Viewpoint - Avadel Pharmaceuticals plc will host a conference call on August 7, 2025, to provide a corporate update and discuss its financial results for Q2 2025 [1]. Company Overview - Avadel Pharmaceuticals plc is a biopharmaceutical company focused on transforming medicines to improve patients' lives [3]. - The company’s commercial product, LUMRYZ™, is the first and only once-at-bedtime oxybate approved by the FDA for treating cataplexy or excessive daytime sleepiness in patients aged 7 and older with narcolepsy [3]. Event Details - The conference call will take place at 8:30 a.m. ET [1]. - A live audio webcast of the call can be accessed through the investor relations section of the company's website, and a replay will be available for 90 days [2]. - Participants are advised to register at least 10 minutes prior to the call [2].